+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Soft Tissue Biologics"

Japan Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

Japan Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 55 Pages
  • Japan
From
Brazil Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

Brazil Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 52 Pages
  • Brazil
From
Mexico Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

Mexico Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 58 Pages
  • Mexico
From
South Korea Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

South Korea Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 50 Pages
  • South Korea
From
Russia Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

Russia Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 52 Pages
  • Russia
From
Spain Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

Spain Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 52 Pages
  • Spain
From
Italy Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

Italy Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 50 Pages
  • Italy
From
United Kingdom Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation - Product Thumbnail Image

United Kingdom Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

  • Report
  • April 2026
  • 64 Pages
  • United Kingdom
From
Mexico Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

Mexico Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • Mexico
From
Italy Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

Italy Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • Italy
From
France Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

France Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • France
From
China Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

China Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • China
From
BRIC Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

BRIC Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 99 Pages
  • Brazil, China, India, ... Brazil, China, India, Russia
From
United States of America (USA) Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

United States of America (USA) Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • United States
From
United Kingdom (UK) Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

United Kingdom (UK) Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • United Kingdom
From
Spain Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

Spain Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • Spain
From
South Korea Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

South Korea Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • South Korea
From
Russia Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030 - Product Thumbnail Image

Russia Orthobiologic Procedures Count by Segments (Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures and Others) and Forecast, 2015-2030

  • Report
  • January 2023
  • 32 Pages
  • Russia
From
Loading Indicator

Soft tissue biologics are a category of biotechnological products used in regenerative medicine, wound care, and various medical procedures that aim to repair or replace damaged or insufficient soft tissues. These biologics are derived from human, animal, or synthetic sources and are designed to provide structural support, enhance tissue regeneration, and promote healing. The market for soft tissue biologics encompasses a range of products including collagen matrices, growth factors, stem cells, and other biomaterials that are commonly used in orthopedics, dentistry, and dermatology. Advancements in biotechnology have led to the development of more sophisticated and efficacious biologic materials that closely mimic the natural properties of human tissues, thereby improving patient outcomes. Key players in the soft tissue biologics market include Allergan, Athersys Inc., Organogenesis Inc., Integra LifeSciences, Zimmer Biomet, Stryker Corporation, and Medtronic. These companies engage in extensive research and development endeavors to produce and improve soft tissue biologics that offer novel solutions for the restoration of soft tissues, addressing a variety of medical conditions and injuries. Additionally, they focus on obtaining regulatory approvals, fostering innovation, and expanding the clinical applications of their products. Show Less Read more